RxDoctor Payments Data

Christina Daoud, DO

Family Medicine · Coldwater, MINPI 1235123175

Payments from drug & device makers

$1,442in general payments, 2019–2025

Across 88 payments — averaging $16.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$290
  • Lilly USA, LLC$196
  • Novo Nordisk$176
  • AbbVie$117
  • AstraZeneca$98
  • Exact Sciences$95
  • plus $471 from 17 others

What the payments were for

  • Food & beverage$1,442100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,442 in reported general payments places this provider in the 75th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$31,793
Medicare patients
82
Services billed
400

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide22$27,901
OzempicSemaglutide17$20,968
TradjentaLinagliptin24$16,372
Breo ElliptaFluticasone/Vilanterol32$15,714
JanuviaSitagliptin Phosphate14$15,535
XareltoRivaroxaban17$12,568
Tresiba Flextouch U-200Insulin Degludec12$12,118
Tresiba Flextouch U-100Insulin Degludec14$7,490
Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide29$2,947
Valsartan51$2,028
Atorvastatin Calcium161$1,754
Sertraline Hcl125$1,273
Potassium Chloride35$1,206
Metoprolol Succinate65$1,196
Albuterol Sulfate HfaAlbuterol Sulfate29$1,107

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$196$27,90122 claims
Novo NordiskOzempic$176$20,96817 claims
Boehringer IngelheimTradjenta$32$16,37224 claims
GSKBreo Ellipta$40$15,71432 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Coldwater

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →